These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27401656)

  • 21. Inherited and acquired thrombophilia: pregnancy outcome and treatment.
    De Santis M; Cavaliere AF; Straface G; Di Gianantonio E; Caruso A
    Reprod Toxicol; 2006 Aug; 22(2):227-33. PubMed ID: 16797917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Our experience with management of inherited thrombophilia during pregnancy: preliminary report].
    Marinov B; Pramatarova T; Andreeva A; Iarukova N; Slavov A
    Akush Ginekol (Sofiia); 2011; 50 Suppl 2():28-31. PubMed ID: 22524136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias.
    Kupferminc MJ; Fait G; Many A; Lessing JB; Yair D; Bar-Am A; Eldor A
    Hypertens Pregnancy; 2001; 20(1):35-44. PubMed ID: 12044312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis and treatment of thrombophilia in pregnancy.
    Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
    Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study.
    Conserva V; Muggiasca M; Arrigoni L; Mantegazza V; Rossi E; Ferrazzi E
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1467-73. PubMed ID: 22122225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombophilia, anticoagulant therapy and pregnancy].
    Boda Z; László P; Pfliegler G; Tornai I; Rejtö L; Schlammadinger A
    Orv Hetil; 1998 Dec; 139(52):3113-6. PubMed ID: 9914731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
    Jusić A; Balić D; Avdić A; Pođanin M; Balić A
    Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
    Areia AL; Fonseca E; Areia M; Moura P
    Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is thrombophilia a risk factor for placenta-mediated pregnancy complications?
    Hoffmann E; Hedlund E; Perin T; Lyndrup J
    Arch Gynecol Obstet; 2012 Sep; 286(3):585-9. PubMed ID: 22543699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherited and acquired thrombophilias.
    Rambaldi MP; Mecacci F; Guaschino S; Paidas MJ
    Reprod Sci; 2014 Feb; 21(2):167-82. PubMed ID: 23899550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications.
    Bar J; Mashiah R; Cohen-Sacher B; Hod M; Orvieto R; Ben-Rafael Z; Lahav J
    Thromb Res; 2001 Feb; 101(4):235-41. PubMed ID: 11248284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome.
    Gat I; Dulitzki M; Schiff E; Sivan E; Simchen MJ
    Isr Med Assoc J; 2014 Feb; 16(2):96-100. PubMed ID: 24645228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Our experience with management of inherited thrombophilia during pregnancy. Preliminary report].
    Marinov B; Pramatarova T; Andreeva A; Iarukova N; Slavov A
    Akush Ginekol (Sofiia); 2011; 50(6):15-7. PubMed ID: 22452061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia.
    Leduc L; Dubois E; Takser L; Rey E; David M
    J Obstet Gynaecol Can; 2007 Oct; 29(10):787-93. PubMed ID: 17915061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of heparin in women with early and late miscarriages with and without thrombophilia.
    Monien S; Kadecki O; Baumgarten S; Salama A; Dörner T; Kiesewetter H
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):636-44. PubMed ID: 19666941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia.
    Many A; Elad R; Yaron Y; Eldor A; Lessing JB; Kupferminc MJ
    Obstet Gynecol; 2002 May; 99(5 Pt 1):684-7. PubMed ID: 11978272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].
    Paskaleva I; Karagiozova Zh; Doncheva E; Dineva D
    Akush Ginekol (Sofiia); 2014; 53(2):3-10. PubMed ID: 25098102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited thrombophilia and poor pregnancy outcome.
    Brenner B; Kupferminc MJ
    Best Pract Res Clin Obstet Gynaecol; 2003 Jun; 17(3):427-39. PubMed ID: 12787536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.